Deutsche Bank
ASMB icon

Deutsche Bank’s Assembly Biosciences ASMB Stock Holding History

Deutsche Bank’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Buy
+9,615
New +$262K ﹤0.01% 3107
2021
Q2 		– Sell
-1,724
Closed -$96K – 4591
2021
Q1 		$96K Sell
1,724
-156
-8% -$10.3K ﹤0.01% 3996
2020
Q4 		$137K Buy
1,880
+55
+3% +$6.45K ﹤0.01% 3668
2020
Q3 		$361K Buy
1,825
+281
+18% +$70.8K ﹤0.01% 2834
2020
Q2 		$432K Sell
1,544
-2,721
-64% -$635K ﹤0.01% 2729
2020
Q1 		$758K Sell
4,265
-1,396
-25% -$299K ﹤0.01% 2247
2019
Q4 		$1.39M Sell
5,661
-6,376
-53% -$1.17M ﹤0.01% 2185
2019
Q3 		$1.42M Sell
12,037
-5,363
-31% -$811K ﹤0.01% 2117
2019
Q2 		$2.81M Buy
17,400
+11,604
+200% +$2.21M ﹤0.01% 2170
2019
Q1 		$1.37M Buy
5,796
+1,245
+27% +$315K ﹤0.01% 2773
2018
Q4 		$1.23M Sell
4,551
-984
-18% -$285K ﹤0.01% 2734
2018
Q3 		$2.47M Sell
5,535
-38
-0.7% -$17.8K ﹤0.01% 2718
2018
Q2 		$2.62M Buy
5,573
+3,338
+149% +$1.77M ﹤0.01% 2781
2018
Q1 		$1.32M Sell
2,235
-724
-24% -$449K ﹤0.01% 3146
2017
Q4 		$1.6M Sell
2,959
-1,830
-38% -$828K ﹤0.01% 2884
2017
Q3 		$2M Buy
4,789
+542
+13% +$166K ﹤0.01% 2541
2017
Q2 		$1.05M Buy
4,247
+3,414
+410% +$961K ﹤0.01% 3001
2017
Q1 		$254K Buy
833
+50
+6% +$12.3K ﹤0.01% 3462
2016
Q4 		$114K Buy
+783
New +$116K ﹤0.01% 4007
2016
Q3 		– Sell
-1,381
Closed -$91K – 4898
2016
Q2 		$91K Buy
1,381
+148
+12% +$9.71K ﹤0.01% 4156
2016
Q1 		$73K Buy
1,233
+836
+211% +$55.9K ﹤0.01% 4173
2015
Q4 		$35K Buy
397
+67
+20% +$7.3K ﹤0.01% 4563
2015
Q3 		$37K Buy
330
+43
+15% +$7.56K ﹤0.01% 4559
2015
Q2 		$66K Buy
+287
New +$55.4K ﹤0.01% 4453
2014
Q2 		– Sell
-1,441
Closed -$109K – 5869
2014
Q1 		$109K Sell
1,441
-1,444
-50% -$225K ﹤0.01% 4191
2013
Q4 		$659K Sell
2,885
-5,145
-64% -$937K ﹤0.01% 2910
2013
Q3 		$1.39M Sell
8,030
-1,605
-17% -$246K ﹤0.01% 2711
2013
Q2 		$1.39M Buy
+9,635
New +$1.51M ﹤0.01% 2467

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Deutsche Bank's ASMB Position: Q2 2026 in Review

Deutsche Bank opened a new position in Assembly Biosciences (ASMB) in Q2 2026: 9,615 shares worth $264K. The stake represents ﹤0.01% of the portfolio and ranks #3107 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in ASMB as recently as Q1 2021.

Deutsche Bank first reported a position in ASMB in Q2 2013 and has held it in 28 quarters since. The position peaked at $2.81M in Q2 2019. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Deutsche Bank held 9,615 shares of Assembly Biosciences worth $264K as of Q2 2026.
  • Assembly Biosciences was a new Deutsche Bank position in Q2 2026.
  • Assembly Biosciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3107 holding.
  • Deutsche Bank first reported a position in Assembly Biosciences in Q2 2013 and has held it in 28 quarters since.
  • Deutsche Bank's Assembly Biosciences position peaked at $2.81M in Q2 2019.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.